Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial.
- Submitting institution
-
University of Oxford
- Unit of assessment
- 2 - Public Health, Health Services and Primary Care
- Output identifier
- 6000
- Type
- D - Journal article
- DOI
-
10.1016/s0140-6736(14)61095-3
- Title of journal
- Lancet (London, England)
- Article number
- -
- First page
- 1684
- Volume
- 384
- Issue
- 9955
- ISSN
- 0140-6736
- Open access status
- Out of scope for open access requirements
- Month of publication
- November
- Year of publication
- 2014
- URL
-
-
- Supplementary information
-
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2814%2961095-3/fulltext?rss=yes#supplementaryMaterial
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
8
- Research group(s)
-
-
- Citation count
- 79
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
